1 December 2007 in Journal of Occupational Medicine and Toxicology
Nanoparticles hold tremendous potential as an effective drug delivery system. In this review we discussed recent developments in nanotechnology for drug delivery. To overcome the problems of gene and drug delivery, nanotechnology has gained interest in recent years. Nanosystems with different compositions and biological properties have been extensively investigated for drug and gene delivery applications. To achieve efficient drug delivery it is important to understand the interactions of nanomaterials with the biological environment, targeting cell-surface receptors, drug release, multiple drug administration, stability of therapeutic agents and molecular mechanisms of cell signalling involved in pathobiology of the disease under consideration. Several anti-cancer drugs including paclitaxel, doxorubicin, 5-fluorouracil and dexamethasone have been successfully formulated using nanomaterials. Quantom dots, chitosan, Polylactic/glycolic acid (PLGA) and PLGA-based nanoparticles have also been used for in vitro RNAi delivery. Brain cancer is one of the most difficult malignancies to detect and treat mainly because of the difficulty in getting imaging and therapeutic agents past the blood-brain barrier and into the brain. Anti-cancer drugs such as loperamide and doxorubicin bound to nanomaterials have been shown to cross the intact blood-brain barrier and released at therapeutic concentrations in the brain. The use of nanomaterials including peptide-based nanotubes to target the vascular endothelial growth factor (VEGF) receptor and cell adhesion molecules like integrins, cadherins and selectins, is a new approach to control disease progression.
15 August 1999 in Journal of Clinical Investigation
Endothelial responses may contribute importantly to the pathology of high vascular pressure. In lung venular capillaries, we determined endothelial [Ca2+]i by the fura-2 ratioing method and fusion pore formation by quantifying the fluorescence of FM1-43. Pressure elevation increased endothelial [Ca2+]i. Concomitantly evoked exocytotic events were evident in a novel spatial-temporal pattern of fusion pore formation. Fusion pores formed predominantly at vascular branch points and colocalized with the expression of P-selectin. Blockade of mechanogated Ca2+ channels inhibited these responses, identifying entry of external Ca2+ as the critical triggering mechanism. These endothelial responses point to a proinflammatory effect of high vascular pressure that may be relevant in the pathogenesis of pressure-induced lung disease. J. Clin. Invest.104:495-502 (1999).
15 March 2012 in American Journal of Physiology-Lung Cellular and Molecular Physiology
Pulmonary intravascular macrophages (PIMs) are constitutively found in species such as cattle, horse, pig, sheep, goat, cats, and whales and can be induced in species such as rats, which normally lack them. It is believed that human lung lacks PIMs, but there are previous suggestions of their induction in patients suffering from liver dysfunction. Recent data show induction of PIMs in bile-duct ligated rats and humans suffering from hepato-pulmonary syndrome. Because constitutive and induced PIMs are pro-inflammatory in response to endotoxins and bacteria, there is a need to study their biology in inflammatory lung diseases such as sepsis, asthma, chronic obstructive pulmonary diseases, or hepato-pulmonary syndrome. We provide a review of PIM biology to make an argument for increased emphasis and better focus on the study of human PIMs to better understand their potential role in the pathophysiology and mechanisms of pulmonary diseases.
1 January 2000 in American Journal of Physiology-Lung Cellular and Molecular Physiology
The expression of the αvβ3-integrin in nonproliferating vascular beds remains unclear. To determine possible organ-specific differences, we compared αvβ3-integrin expression in the lung and other organs. Paraffin-embedded tissue sections of lung, liver, brain, muscle and skin obtained from rats were processed for immunohistochemistry with a monoclonal (LM609) and a polyclonal antibody (AB1903) against the αvβ3-integrin. Immunogold electron microscopy was used to localize αvβ3-integrin in rat lung microvasculature. With the use of custom-designed primers, lung sections were subjected to in situ PCR in a thermal cycler to amplify αvor β3mRNA. To confirm specific amplification, PCR products were further hybridized in situ with an αvor β3cDNA probe. In the lung, the αvβ3-integrin protein as well as αvand β3mRNAs was extensively evident in the endothelium of extra-alveolar and alveolar microvessels, in vascular smooth muscle, and in large bronchial epithelium but not in the epithelium of alveolar ducts or alveoli. Ultrastructural immunogold labeling showed the presence of the integrin on the luminal and abluminal faces of the lung microvascular endothelium but not on the apical surface of the alveolar epithelium. Staining for the integrin was generally negative in blood vessels of several systemic organs, although weak staining was evident in branches of the hepatic portal vein. The constitutive presence of the αvand β3mRNAs and the αvβ3-integrin in the lung microvascular bed suggests that gene transcription for the integrin is ongoing in lung vessels. Because it binds vitronectin, the lung vascular αvβ3-integrin may play a role in ligation of bloodborne, vitronectin-containing macromolecular complexes formed in inflammation.
8 September 2010 in Cell and tissue research
10 June 2009 in Journal of Occupational Medicine and Toxicology
The Canadian poultry production industry contributes nearly $10 billion to the Canadian economy and employs nearly 50,000 workers. However, modern poultry facilities are highly contaminated with airborne dust. Although there are many bioaerosols in the poultry barn environment, endotoxin is typically attributed with the negative respiratory symptoms observed in workers. These adverse respiratory symptoms have a higher prevalence in poultry workers compared to workers from other animal confinement buildings. Workers in cage-housed operations compared to floor-housed facilities report a higher prevalence of some respiratory symptoms. We review the current state of knowledge on airborne dust in poultry barns and respiratory dysfunction in poultry workers while highlighting the areas that need further investigation. Our review focuses on the aerobiological pathway of poultry dust including the source and aerosolization of dust and worker exposure and response. Further understanding of the source and aerosolization of dust in poultry operations will aid in the development of management practices to reduce worker exposure and response.